An epidemiological analysis of the 'autism as mercury poisoning' hypothesis

International Journal of Risk and Safety in Medicine

Volumn 20, Issue 3, 2008, Pages 135-142

  Austin, David ^a  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Autism; Epidemiology; Mercury; Pink disease; Precautionary principle

Indexed keywords

MERCURY;

ACRODYNIA; AUTISM; CIGARETTE SMOKING; HEALTH CARE PERSONNEL; HUMAN; LUNG CANCER; MERCURIALISM; NERVE CELL DIFFERENTIATION; NONHUMAN; PREVALENCE; REVIEW; RISK FACTOR; WORLD HEALTH ORGANIZATION;

EID: 50249157919     PISSN: 09246479     EISSN: None     Source Type: Journal    
DOI: 10.3233/JRS-2008-0436     Document Type: Review

References (49)

1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 4th edn, APA, Washington, DC, 1994.
2. The Autism Genome Project Consortium, Mapping autism risk loci using genetic linkage and chromosomal rearrangements, Nature Genetics 39 (2007), 319-328.
3. C. Beck, B. Krafchik, J. Traubici and S. Jacobson, Mercury intoxication: It still exists, Pediatric Dermatology 21(3) (2004), 254-259.
4. S. Bernard, A. Enayati, L. Redwood, H. Roger and T. Binstock, Autism: A novel form of mercury poisoning, Medical Hypotheses 56(4) (2001), 462-471.
5. M.F. Blaxill, D.S. Baskin and W.O. Spitzer, Commentary: Blaxill, Baskin, and Spitzer on Croen et al. (2002), The changing prevalence of autism in California, Journal of Autism and Developmental Disorders 33 (2003), 223-226.
6. J. Bradstreet, D.A. Geier, J.J. Kartzinel, J.B. Adams and M.R. Geier, A case-control study of mercury burden in children with autistic spectrum disorders, Journal of American Physicians and Surgeons 8(3) 2003, 76-79.
7. D.B. Campbell, J.S. Sutcliffe, P.J. Ebert and R. Militerni, From the cover: A genetic variant that disrupts MET transcription is associated with autism, Proceedings of the National Academy of Sciences 103(45) (2006), 16834-16839.
8. Centers for Disease Control and Prevention, Autism spectrum disorders overview, http://www.cdc.gov/ncbddd/autism/overview.htm#who (retrieved July 15, 2008).
9. D.C. Chagani, O. Muzik, M. Behen et al., Developmental changes in brain seratonin synthesis capacity in autistic and non-autistic children, Annals of Neurology 45 (1999), 287-295.
10. T.W. Clarkson, L. Magos and G.J. Myers, The toxicology of mercury - current exposures and clinical manifestations, New England Journal of Medicine 349(18) (2003), 1731-1737.
11. H.H. Cohly and A. Panja, Immunological findings in autism, International Review of Neurobiology 71 (2005), 317-341.
12. L.A. Croen, J.K. Grether, J. Hoogstrate and S. Selvin, The changing prevalence of autism in California, Journal of Autism and Developmental Disorders 32 (2002), 207-215.
13. A. Dally, The rise and fall of pink disease, Social History of Medicine 10(2) (1979), 291-304.
14. G. Dawson, S. Webb, G.D. Schellenberg and S. Dager, Defining the broader phenotype of autism: Genetic, brain, and behavioral perspectives, Development and Psychopathology 14 (2002), 581-611.
15. M.C. DeSoto and R.T. Hitlan, Blood levels of mercury are related to diagnosis of autism: A reanalysis of an important data set, Journal of Child Neurology 22(11) (2007), 1308-1311.
16. D.A. Geier and M.R. Geier, A prospective assessment of porphyrins in autistic disorders: A potential marker for heavy metal exposure, Neurotoxicity Research 10(1) (2006), 57-64.
17. D.A. Geier and M.R. Geier, A case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders, Journal of Toxicology and Environmental Health 70 (2007), 837-851.
18. M.R. Geier and D.A. Geier, Neurodevelopmental disorders after thimerosal-containing vaccines: A brief communication, Experimental Biological Medicine 228(6) (2003), 660-664.
19. L.R. Goldfrank, N.E. Flomenbaum, N.A. Lewin, M.A. Howland and R.S. Hoffman (eds), Goldfrank's Toxicology Emergencies, 7th edn, McGraw-Hill, New York, 2002.
20. B.D. Goldstein, The precautionary principle also applies to public health actions, American Journal of Public Health 91(9) (2001), 1358-1361.
21. B.E. Haley, Mercury toxicity: Genetic susceptibility and synergistic effects, Medical Veritas 2 (2005), 535-542.
22. M. Hornig, D. Chian and W.I. Lipkin, Neurotoxic effects of postnatal thimerosal are mouse-strain dependent, Molecular Psychiatry 9 (2004), 833-845.
23. K. Horvath and J.A. Perman, Autism and gastrointestinal symptoms, Current Gastroenterology Reports 4(3) 2002, 251-258.
24. A. Hviid, M. Stellfeld, J. Wohlfahrt and M. Melbye, Association between thimerosal-containing vaccine and autism, JAMA 290 (2003), 1763-1766.
25. S.J. James, P. Cutler, S. Melnyk, S. Jernigan, L. Janak, D. Gaylor and J.A. Neubrander, Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism, American Journal of Clinical Nutrition 80 (2004), 1611-1617.
26. L. Kanner, Autistic disturbances of affective contact, Nervous Child 2 (1943), 217-250.
27. J. Kern and A.M. Jones, Evidence of toxicity, oxidative stress, and neuronal insult in autism, Journal of Toxicology and Environmental Health 9 (2006), 485-499.
28. J. Mutter, J. Naumann, R. Schneider, H. Walach and B. Haley, Mercury and autism: Accelerating evidence?, Neuroendicronology Letters 26(5) (2005), 439-446.
29. R. Nataf, C. Skorupka, L. Amet, A. Lam, A. Springbett and R. Lathe, Porphyrinuria in childhood autistic disorder: Implications for environmental toxicity, Toxicology and Applied Pharmacology 214 (2006), 99-108.
30. R.F. Palmer, S. Blanchard, Z. Stein, D. Mandell and C. Miller, Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas, Health & Place 12 (2006), 203-209.
31. Paracelsus, The Hermetic And Alchemical Writings Of Paracelsus, Two Vols, translated by Arthur Edward Waite, London, 1894.
32. M. Parascondola, D.L. Weed and A. Dasgupta, Two surgeon general's reports on smoking and cancer: a historical investigation of the practice of causal inference, Emerging Themes in Epidemiology 3(1) (2006), 1-11; http://www.ete-online.com/content/3/1/1 (retrieved January 17, 2008).
33. C. Rocaz, Pink Disease (Infantile Acrodynia), translated by I.J. Wood from L'Acrodynie Infantile, London, 1933.
34. E. Schoepler, C.E. Andrews and K. Strupp, Do autistic children come from upper-middle-class parents?, Journal of Autism and Developmental Disorders 9(2) (1979), 139-152.
35. D.A. Skaar, Y. Shao, J.L. Haines and J.E. Stenger, Analysis of the RELN gene as a genetic risk factor for autism, Molecular Psychiatry 10 (2005), 563-571.
36. J.I. Soler, J. Ellacuria, R. Triana, E. Guinea and J.W. Osborne, A history of dental amalgam, Journal of the History of Dentistry 50(3) (2002), 109-116.
37. G.V. Stajich, G.P. Lopez, S.W. Harry and W.R. Sexson, Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants, Journal of Pediatrics 136 (2000), 679-681.
38. US Department of Health, Education and Welfare, Smoking and health, Report of the Advisory Committee to the Surgeon General of the Public Health Service, Washington, DC, USA, 1964.
39. US Food and Drug Administration, Center for Biologics Evaluation and Research, Thimerosal in vaccines (2007-09-06) (retrieved on 2007-10-01).
40. D.L. Vargas, C. Nacimbene, C. Krishnan, A.W. Zimmerman and C.A. Pardo, Neuroglial activation and neuroinflammation in the brain of patients with autism, Annals of Neurology 57(1) (2005), 67-81.
41. T. Verstraeten, R.L. Davis and F. DeStefano, Thimerosal VSD study phase 1 (29/02/2000), obtained via Freedom of Information Act USA.
42. T. Verstraeten, R.L. Davis, F. DeStefano, T.A. Lieu, P.H. Rhodes, S.B. Black, H. Shinefield and R.T. Chen, Safety of Thimerosal-containing vaccines: A two-phased study of computerized health maintenance organization databases, Pediatrics 112(5) (2003), 1039-1048.
43. J. Warkany and D.M. Hubbard, Mercury in the urine of chilsren with acrodynia, Lancet 1 (1948), 829-838.
44. D.L. Weed, Environmental epidemiology: Basics and proof of cause-effect, Toxicology 181/182 (2002), 399-403.
45. Q. Whishaw, The laboratory rat, the Pied Piper of twentieth century neuroscience, Brain Research Bulletin 50(5/6) (1999), 411.
46. World Health Organization, Consensus statement on dental amalgam, 7 March 1997, WHO, Geneva, 1999.
47. E.F. Yazbak, Autism in the United States: a perspective, Journal of American Physicians and Surgeons 8 (2003), 103-107.
48. T. Ylisaukko-oja, M. Alarcon, R.M. Cantor and M. Auranen, Search for autism loci by combined analysis of autism genetic resource exchange and Finnish families, Annals of Neurology 59(1) (2006), 145-155.
49. J. Zubin and B. Spring, Vulnerability - A new view of schizophrenia, Journal of Abnormal Psychology 86(2) (1977), 103-126.